Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-26 23:09 | 2023-10-24 | ARQT | Arcutis Biotherapeutics Inc. | Frazier Life Sciences VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $2.50 | 80,000 | $200,000 | 8,764,232 | +0.9% |
| 2022-08-09 23:34 | 2022-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Frazier Life Sciences VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 250,000 | $5,000,000 | 8,684,232 | +3.0% |
| 2022-02-16 01:00 | 2022-02-11 | ALPN | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | BUY | $7.10 | 112,665 | $799,989 | 1,484,115 | +8.2% |
| 2020-02-06 18:29 | 2020-02-04 | ARQT | Arcutis Biotherapeutics Inc. | Frazier Life Sciences VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 500,000 | $8,500,000 | 10,542,790 | +5.0% |
| 2020-01-13 18:47 | 2020-01-09 | ETTX | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | SALE | $5.00 | 50,000 | $250,010 | 1,299,953 | -3.7% |
| 2019-01-23 01:14 | 2019-01-18 | ALPN | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | BUY | $5.37 | 372,439 | $1,999,997 | 2,571,450 | +16.9% |
| 2018-10-03 04:38 | 2018-09-28 | ETTX | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | BUY | $15.00 | 375,887 | $5,638,305 | 1,349,953 | +38.6% |
| 2018-06-26 23:56 | 2018-06-25 | APTX | N/A | Frazier Life Sciences VIII, L.P. | 10% owner | Other | BUY | $16.00 | 150,000 | $2,400,000 | 3,190,079 | +4.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.